| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |